Zacks.com on MSN18h
CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease
AstraZeneca AZN announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...
At home, no needle: FDA approves first at-home flu shot
A new weapon against flu is now approved by the Food and Drug Administration (FDA).
Pharmaceutical Technology1d
EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approving ...
Renal & Urology News1d
FDA Approves Fasenra for Eosinophilic Granulomatosis With Polyangiitis
The FDA has approved Fasenra® (benralizumab) for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis.
WebMD1d
FDA Approves First At-Home Nasal Flu Vaccine
The FDA has OK'd FluMist, a nasal spray flu vaccine that you can give and get at home – no health care provider needed. It’s the first flu vaccine of its kind, offering a simple, convenient, ...
TAG24 NEWS on MSN3d
FDA approves a first-of-a-kind flu vaccine in the form of a nasal spray!
In a first, the Food and Drug Administration on Friday approved AstraZeneca's FluMist, a nasal spray flu vaccine that anyone ...
Daily4d
AstraZeneca FluMist gets USFDA nod for self-administered influenza vaccine
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
Jefferson Public Radio4d
No needles required: The FDA approves an at-home flu vaccine
The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
MedPage Today6d
FDA OKs New Option for Rare Immune-Mediated Vasculitis
EGPA, previously known as Churg-Strauss syndrome, is a rare inflammatory disorder characterized by asthma, necrotizing ...